FORA vs INFU

For growth investors, Forian Inc.

(FORA) is the stronger pick with 50. 1% revenue growth year-over-year, versus 6. 4% for InfuSystem Holdings, Inc. (INFU). InfuSystem Holdings, Inc. (INFU) offers the better valuation at 30. 4x trailing P/E (22. 2x forward), making it the more compelling value choice. Analysts rate InfuSystem Holdings, Inc. (INFU) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, InfuSystem Holdings, Inc.

(INFU) delivered a total return of -50. 2%, compared to -82. 7% for Forian Inc. (FORA). Over 10 years, the gap is even starker: INFU returned +240. 1% versus FORA's -90. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Forian Inc.

(FORA) is the lower-risk stock at 0. 21β versus InfuSystem Holdings, Inc. 's 1. 22β — meaning INFU is approximately 480% more volatile than FORA relative to the S&P 500. On balance sheet safety, Forian Inc. (FORA) carries a lower debt/equity ratio of 0% versus 6% for InfuSystem Holdings, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Forian Inc.

(FORA) is pulling ahead at 50. 1% versus 6. 4% for InfuSystem Holdings, Inc. (INFU). On earnings-per-share growth, the picture is similar: InfuSystem Holdings, Inc. grew EPS 181. 8% year-over-year, compared to 23. 0% for Forian Inc.. Over a 3-year CAGR, FORA leads at 22. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

InfuSystem Holdings, Inc.

(INFU) is the more profitable company, earning 4. 6% net margin versus -9. 5% for Forian Inc. — meaning it keeps 4. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INFU leads at 8. 3% versus -8. 2% for FORA. At the gross margin level — before operating expenses — INFU leads at 56. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Forian Inc.

(FORA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 21)). Both have compounded well over 10 years (FORA: -90. 5%, INFU: +240. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: FORA is a small-cap high-growth stock; INFU is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.